Abstract
It is not known how the protein Bcl-2 inhibits cell death induced by calcium signalling and growth-factor withdrawal1–3. Here we report that Bcl-2 forms a tight complex with calcineurin, resulting in the targeting of calcineurin to Bcl-2 sites on cytoplasmic membranes, and show that this interaction is dependent on the BH4 domain of Bcl-2. Calcineurin bound to Bcl-2 is an active phosphatase but is unable to promote the nuclear translocation of NF-AT, a transcription-factor required for induction of interleukin-2 expression, suggesting a mechanism by which Bcl-2 suppresses NF-AT activity4. We also show that Bax, a pro-apoptotic member of the Bcl-2 family, interferes with interactions between calcineurin and Bcl-2. We propose that the ability of Bcl-2 to block NF-AT signalling is due to the sequestering of active calcineurin to the same domain of Bcl-2 which associates with Rad-1 (ref. 5), and that calcineurin may act in Bcl-2-regulated functions.
Similar content being viewed by others
References
Reed, J. C. Bcl-2 and regulation of programmed cell death J. Cell Biol. 124, 1–6 ( 1994).
Oltvai, Z. N., Milliman, C. L. & Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609–619 ( 1993).
Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456–1462 ( 1995).
Linette, G. P., Li, Y., Roth, K. & Korsmeyer, S. J. Cross talk between cell death and cell cycle progression: Bcl-2 regulates NFAT-mediated activation. Proc. Natl Acad. Sci. USA 93, 9545–9552 ( 1996).
Wang, H.-G., Rapp, U. R. & Reed, J. C. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87, 629–638 ( 1996).
Shibasaki, F. & McKeon, F. Calcineurin functions in Ca2+-activated cell death in mammalian cells. J. Cell Biol. 131, 735–743 ( 1995).
Braun, W., Kallen, J., Mikol, V., Walkinshaw, M. D. & Wuthrich, K. Three-dimensional structure and actions of immunosuppressants and their immunophilins. FASEB J. 9, 63–72 ( 1995).
Kondo, E. et al. Detection of bcl-2 protein and bcl-2 messenger RNA in normal and neoplastic lymphoid tissues by immunohistochemistry and in situ hybridization. Blood 80, 2044–2051 ( 1992).
Krajewski, S. et al. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53, 4701–4714 ( 1993).
Gonzalez-Garcia M. et al. Bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development 20, 3033–3042 ( 1990).
Yang, T., Kozopas, K. M. & Craig, R. W. The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2. J. Cell Biol. 128, 1173–1184 ( 1995).
Sato, T. et al. Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl Acad. Sci. USA 91, 9238–9242 ( 1994).
Sedlak, T. W. et al. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl Acad. Sci. USA 92, 7834–7838 ( 1995).
Tanaka, S., Saito, K. & Reed, J. C. Structure-function analysis of the Bcl-2 oncoprotein. Addition of a heterologous transmembrane domain to portions of the Bcl-2 beta protein restores function as a regulator of cell survival. J. Biol. Chem. 268, 10920–10926 ( 1993).
Nguyen, M. et al. Role of membrane anchor domain of Bcl-2 in suppression of apoptosis caused by EIB-defective adenovirus. J. Biol. Chem. 239, 16521–16524 ( 1994).
Chalfie, M., Tu, Y., Euskirchen, G., Ward, D. D. & Prasher, D. C. Green fluorescent protein as a marker for gene expression. Science 263, 802–805 ( 1994).
Boise, L. H. et al. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597–608 ( 1993).
Muchmore, S. W. et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381, 335–341 ( 1996).
Shibasaki, F., Price, E. R., Milan, D. & McKeon, F. Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4. Nature 382, 370–373 ( 1996).
Hoey, T., Sun, Y. L., Williamson, K. & Xu, X. Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins. Immunity 2, 461–472 ( 1995).
McDonnell, T. J. et al. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57, 79–88 ( 1989).
Lee, L. C., Hunter, J. J., Mujeeb, A., Turck, C. & Parslow, T. G. Evidence for α-helical conformation of an essential N-terminal region in the human Bcl-2 protein. J. Biol. Chem. 271, 23284–23288 ( 1996).
Zha, H., Aime-Sempe, C., Sato, T. & Reed, J. C. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J. Biol. Chem. 271, 7440–7444 ( 1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shibasaki, F., Kondo, E., Akagi, T. et al. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature 386, 728–731 (1997). https://doi.org/10.1038/386728a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/386728a0
- Springer Nature Limited
This article is cited by
-
CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth
BMC Cancer (2023)
-
Cathepsin K knockout protects against cardiac dysfunction in diabetic mice
Scientific Reports (2017)
-
RETRACTED ARTICLE: Brain injury following cardiac arrest: pathophysiology for neurocritical care
Journal of Intensive Care (2016)
-
Synergistic Bcl-2 inhibition by ABT-737 and cyclosporine A
Apoptosis (2013)
-
RETRACTED ARTICLE: uPAR and cathepsin B downregulation induces apoptosis by targeting calcineurin A to BAD via Bcl-2 in glioma
Journal of Neuro-Oncology (2012)